Differentiation between Wild-Type Group A Rotaviruses and Vaccine Strains in Cases of Suspected Horizontal Transmission and Adverse Events Following Vaccination jacobsen2022differentiation

This study investigates the differentiation between wild-type Group A rotaviruses (RVA) and vaccine strains in cases of suspected horizontal transmission and adverse events following vaccination. Conducted in Germany, the study involved 74 patients, including 68 vaccinated children and 6 cases of suspected horizontal transmission, from 2009 to 2019. The study utilized a PCR-based algorithm to distinguish between vaccine-like and wild-type RVA strains in stool samples. The study found that vaccine-like virus was detected in 46 samples, wild-type RVA in 6 samples, and mixed infections in 3 samples. The study also explored co-infections with other pathogens and the shedding of vaccine strains in immunocompromised patients.

Analytes

stool_rotavirus_vaccine_rv1

Rotarix (RV1) vaccine shedding after vaccination

Biomarker: rotavirus vaccine
Specimen: stool
Units: gc/wet gram
Participants: 18
Negative samples: 0
Positive samples (not quantifiable): 0
Quantifiable samples: 18
Limit of quantification: unknown
Limit of detection: 130000

stool_rotavirus_vaccine_rv5

RotaTeq (RV5) vaccine shedding after vaccination

Biomarker: rotavirus vaccine
Specimen: stool
Units: gc/wet gram
Participants: 10
Negative samples: 0
Positive samples (not quantifiable): 0
Quantifiable samples: 10
Limit of quantification: unknown
Limit of detection: 1300000